Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Obstructive Lung Diseases

  Free Subscription


03.11.2025

2 Allergy
5 Am J Respir Crit Care Med
1 Ann Thorac Surg
2 Clin Exp Allergy
13 J Asthma
1 J Investig Allergol Clin Immunol
1 J Pediatr
2 N Engl J Med
2 Pediatr Allergy Immunol
2 Pediatr Pulmonol
1 Pediatr Rev
3 Pediatrics
2 PLoS One
20 Respir Med
3 Respir Res
1 Rev Mal Respir
1 Thorax


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Allergy

  1. WANIN S, Taam RA, Chami LG, Marguet C, et al
    Characteristics of Adolescents With Uncontrolled Severe Asthma Starting Dupilumab: The PEDIASTHMA Registry.
    Allergy. 2025 Oct 29. doi: 10.1111/all.70119.
    PubMed        

  2. TYNECKA M, Tarasik A, Hanczaruk B, Janucik A, et al
    Dynamic Regulation of Collagens, Proteases, Their Inhibitors, and Cell Death in Experimental Asthma in Mice.
    Allergy. 2025 Oct 28. doi: 10.1111/all.70126.
    PubMed         Abstract available


    Am J Respir Crit Care Med

  3. FAHY JV
    Progress in Treating Mucus Plugs in Asthma.
    Am J Respir Crit Care Med. 2025 Oct 28. doi: 10.1164/rccm.202509-2140.
    PubMed        

  4. PORSBJERG C, Dunican EM, Lugogo NL, Castro M, et al
    Effect of Dupilumab on Mucus Burden in Patients with Moderate-to-Severe Asthma: The VESTIGE Trial.
    Am J Respir Crit Care Med. 2025 Oct 27. doi: 10.1164/rccm.202410-1894.
    PubMed         Abstract available

  5. CHACKO AA, Khairandish Y, Suder JM, Proud KC, et al
    Recent Investigations in Pharmacotherapy for Bronchiectasis.
    Am J Respir Crit Care Med. 2025 Oct 24. doi: 10.1164/rccm.202506-1350.
    PubMed        

  6. SHIM YM, Woods J, Mugler JP
    Breathing Lessons: How Xenon MRI Is Resolving the Overlap Between Asthma and COPD.
    Am J Respir Crit Care Med. 2025 Oct 24. doi: 10.1164/rccm.202509-2258.
    PubMed        

  7. WINKLER T, Fain SB
    Mucus Plugs and Remodeling in the Small Airways: Considerations for Complex Airway Behavior and Instability in Asthma.
    Am J Respir Crit Care Med. 2025 Oct 24. doi: 10.1164/rccm.202508-1859.
    PubMed        


    Ann Thorac Surg

  8. HAYANGA JWA, Luo X, Reddy S, Mehaffey JH, et al
    Endobronchial Valve Therapy vs Lung Volume Reduction Surgery in the United States.
    Ann Thorac Surg. 2025;120:917-925.
    PubMed         Abstract available


    Clin Exp Allergy

  9. PENZ E, Rothe T, Dupont L, Tran TN, et al
    Early and Sustained Asthma Control and Remission in Real-World Patients With Severe Eosinophilic Asthma Treated With Benralizumab: XALOC-2.
    Clin Exp Allergy. 2025 Oct 29. doi: 10.1111/cea.70162.
    PubMed         Abstract available

  10. CHEN X, Feng R, Ji X, Li B, et al
    Management and Research Progress of Severe Asthma in China.
    Clin Exp Allergy. 2025 Oct 25. doi: 10.1111/cea.70166.
    PubMed         Abstract available


    J Asthma

  11. AMAN E, White RN, Stern J, Fagnano M, et al
    Pediatric asthma specialist care utilization among marginalized children with poorly controlled asthma.
    J Asthma. 2025 Oct 29:1-11. doi: 10.1080/02770903.2025.2581016.
    PubMed         Abstract available

  12. FENG Y, Li Y, Wang Y, Li Z, et al
    The global disability-adjusted life years (DALYs) for asthma attributable to nitrogen dioxide pollution from 1990 to 2021 and predicted the trends from 2022 to 2050.
    J Asthma. 2025 Oct 28:1-13. doi: 10.1080/02770903.2025.2577642.
    PubMed         Abstract available

  13. KNUTSEN JC, Callaghan-Koru JA, Moser E, Eakin MN, et al
    Understanding the influence of staff stress during implementation of an asthma program in early childhood education: A qualitative design.
    J Asthma. 2025 Oct 27:1-12. doi: 10.1080/02770903.2025.2581000.
    PubMed         Abstract available

  14. QIN Z, Li L, Wang C
    Association between TYG-BMI index and asthma in adults over 45 years of age: analysis of Global Burden of Disease 2021, China Health and Retirement Longitudinal Study, and National Health and Nutrition Examination Survey data.
    J Asthma. 2025 Oct 30:1-10. doi: 10.1080/02770903.2025.2581787.
    PubMed         Abstract available

  15. TUNC SD, Kaya Dincel G, Metbulut AP, Sayin S, et al
    Assessment of the relationship between asthma severity and cardiac functions using speckle tracking in pediatric patients.
    J Asthma. 2025 Oct 29:1-10. doi: 10.1080/02770903.2025.2581006.
    PubMed         Abstract available

  16. YANG F, Zheng J, Gao M, Ning L, et al
    Association Between Social Determinants of Health and Asthma: A Cross-Sectional Analysis Based on NHANES Data.
    J Asthma. 2025 Oct 24:1-11. doi: 10.1080/02770903.2025.2577637.
    PubMed         Abstract available

  17. LI Z, Zhu S
    STOML2 knockdown inhibits inflammation and airway remodeling of PDGF-BB-induced airway smooth-muscle cells by the MAPK pathway.
    J Asthma. 2025;62:1978-1987.
    PubMed         Abstract available

  18. MOSBECH CHE, Godtfredsen NS Clinical associate professor, Christiansen IS, Bak LK Professor, et al
    Tapering of inhaled corticosteroids in stable T2-low asthma: A randomized trial of symptom- and biomarker trajectories.
    J Asthma. 2025 Oct 29:1-11. doi: 10.1080/02770903.2025.2581018.
    PubMed         Abstract available

  19. LIU N, Luo F, Chen X, Wu Z, et al
    Research on Childhood Asthma and Vitamin D(2003-2023): A Bibliometric Analysis.
    J Asthma. 2025 Oct 29:1-11. doi: 10.1080/02770903.2025.2581015.
    PubMed         Abstract available

  20. ABDELFATTAH HH, Abdelkader AE, Abdelmawgood IA, Kotb MA, et al
    Methylene blue attenuates ovalbumin-induced airway inflammation and oxidative stress in mouse model of asthma.
    J Asthma. 2025 Oct 29:1-11. doi: 10.1080/02770903.2025.2581010.
    PubMed         Abstract available

  21. RIDA J, Bouchriti Y, Achbani A, Sine H, et al
    Asthma control and its predictors: a clinic-based study of demographic, therapeutic, and environmental associations.
    J Asthma. 2025 Oct 30:1-10. doi: 10.1080/02770903.2025.2581789.
    PubMed         Abstract available

  22. MO S, Wang J, Li X, Xie Y, et al
    Causal Relationship Between Fatty Acid Metabolism and Allergic Asthma: A Mendelian Randomization and Multi-Omics Study.
    J Asthma. 2025 Oct 30:1-19. doi: 10.1080/02770903.2025.2580995.
    PubMed         Abstract available

  23. GARCIA-SANCHEZ D, Warren CM, Darssan D, Osborne NJ, et al
    Associations between asthma and the risk of mental and behavioural problems in males.
    J Asthma. 2025 Oct 31:1-16. doi: 10.1080/02770903.2025.2580998.
    PubMed         Abstract available


    J Investig Allergol Clin Immunol

  24. ESTRAVIS M, Carreiras-Quintas D, Trivino JC, Perez-Pazos J, et al
    Identification of Dual Super-Response in Patients With Asthma and CRSwNP Treated With Mepolizumab.
    J Investig Allergol Clin Immunol. 2025 Oct 24:0. doi: 10.18176/jiaci.1102.
    PubMed         Abstract available


    J Pediatr

  25. HALTERMAN JS, Fagnano M, Tremblay PJ, Perry TT, et al
    Effect of the Telemedicine Enhanced Asthma Management-Uniting Providers (TEAM-UP) Program on Asthma Outcomes: A Randomized Clinical Trial.
    J Pediatr. 2025 Oct 23:114872. doi: 10.1016/j.jpeds.2025.114872.
    PubMed         Abstract available


    N Engl J Med

  26. ROLLA G
    As-Needed Albuterol-Budesonide in Mild Asthma.
    N Engl J Med. 2025;393:1755-1756.
    PubMed        

  27. LAFORCE C, Papi A, Bacharier LB
    As-Needed Albuterol-Budesonide in Mild Asthma. Reply.
    N Engl J Med. 2025;393:1756.
    PubMed        


    Pediatr Allergy Immunol

  28. BANDYOPADHYAY A, Jiang B, Shah Y, Owora AH, et al
    Predictive correlates of poor sleep associated with increased risk of severe asthma exacerbations among children with moderate-to-severe asthma.
    Pediatr Allergy Immunol. 2025;36:e70229.
    PubMed         Abstract available


  29. Correction to "Early-life prediction of school-age asthma among recurrent Wheezers in preschoolers: The WHEEP study".
    Pediatr Allergy Immunol. 2025;36:e70236.
    PubMed        


    Pediatr Pulmonol

  30. GIANFRANCESCO L, Malheiro APG, Mazzola TN, Barreto IS, et al
    Phenotype Overlap and Lung Function in Childhood Asthma: The Interaction Between T2 and Non-T2 Responses.
    Pediatr Pulmonol. 2025;60:e71361.
    PubMed         Abstract available

  31. HASSANI M, Barrows J, Young SD
    Systematic Review of Electronic Monitoring to Increase Medication Adherence in Children With Asthma.
    Pediatr Pulmonol. 2025;60:e71355.
    PubMed         Abstract available


    Pediatr Rev

  32. KUNTZMAN K, Koumbourlis A, Ogunlesi F
    Breathing Easier: Optimizing Pulmonary Health in Children With Sickle Cell Disease.
    Pediatr Rev. 2025;46:633-639.
    PubMed         Abstract available


    Pediatrics

  33. LEW A, House S, Flaherty B, Ritter V, et al
    Trends in Lower Respiratory Tract Diagnoses and Nonrecommended Bronchiolitis Therapies.
    Pediatrics. 2025;156:e2025071946.
    PubMed         Abstract available

  34. PAPPALARDO AA, Youssef C, Hardy P, Hingston D, et al
    Stock Inhalers in Chicago Public Schools: Using the RE-AIM Framework to Assess Impact.
    Pediatrics. 2025;156:e2025071143.
    PubMed         Abstract available

  35. RIVERA-SEPULVEDA AV, Harwell CF, Nelson CE, Sarandria J, et al
    Improving Management of Bronchiolitis Across a Primary Care Network.
    Pediatrics. 2025;156:e2024068136.
    PubMed         Abstract available


    PLoS One

  36. CHEN Y, Lin C, Huang R, Chen Q, et al
    Mycoplasma Pneumoniae bronchiolitis and hypoxemia: A retrospective cohort study on risk and prognosis.
    PLoS One. 2025;20:e0335604.
    PubMed         Abstract available

  37. DOS SANTOS AF, Costa R, Pereira H, Pedro AR, et al
    Development and validation of an asthma self-knowledge questionnaire.
    PLoS One. 2025;20:e0333760.
    PubMed         Abstract available


    Respir Med

  38. KOWALCZYK ET, Medubi KM, Meyer MJ, Toriola MA, et al
    Development of novel pegylated imidazobenzodiazepines as inhaled asthma drug candidates.
    Respir Med. 2025 Oct 22:108449. doi: 10.1016/j.rmed.2025.108449.
    PubMed         Abstract available

  39. ZHANG S, Shen K, Sun B, Liu B, et al
    Associations of the prevalence of chronic respiratory diseases and mortality with blood furan levels: a population-based study.
    Respir Med. 2025;248:108422.
    PubMed         Abstract available

  40. SANCHEZ FM, Bommatty MS, Haro MQ, Ruiz FO, et al
    Telemonitoring in patients with COPD: A prospective study with results from the AIRE project.
    Respir Med. 2025;248:108307.
    PubMed         Abstract available

  41. SEPULVEDA-LOYOLA W, Tang C, Alvarez-Bustos A, Cuyul-Vasquez I, et al
    Exploring pulmonary rehabilitation programs implemented and conducted in Latin America for people with chronic respiratory conditions: A scoping review.
    Respir Med. 2025;248:108310.
    PubMed         Abstract available

  42. MOUROUVIN-CHEVOLOT E, Laurent L, Claude F, Westeel V, et al
    Distinctive computed tomography features of chronic obstructive pulmonary disease among dairy farmers and smokers.
    Respir Med. 2025;248:108319.
    PubMed         Abstract available

  43. CAZZOLA M, Hanania NA, Rogliani P
    Comorbidities as treatable traits of chronic airway diseases.
    Respir Med. 2025;248:108333.
    PubMed         Abstract available

  44. BHUTANI M, Mullerova H, Patel D, Barjaktarevic I, et al
    Disease burden and health-related outcomes of patients discharged from hospital following a COPD exacerbation in the United States.
    Respir Med. 2025;248:108337.
    PubMed         Abstract available

  45. SUTER P, Greig R, Chan R, Lipworth B, et al
    Efficacy of dupilumab and mepolizumab in eosinophilic COPD: insights from phase 3 trials.
    Respir Med. 2025;248:108343.
    PubMed         Abstract available

  46. NIELSEN LB, Olsson M, Weinreich UM, Ekstrom M, et al
    Associations between chronic airflow limitation, respiratory symptoms, and quality of life across alcohol use categories: a population based study.
    Respir Med. 2025;248:108350.
    PubMed         Abstract available

  47. TSILIGIANNI I, Papageorgakopoulou S, Bouloukaki I
    Adherence to the Chronic Obstructive Pulmonary Disease guidelines in primary care: The Greek COPD COCARE study.
    Respir Med. 2025;248:108345.
    PubMed         Abstract available

  48. WU SC, Wu CY, Chien JY, Dong YH, et al
    Predicting response to inhaled corticosteroid maintenance therapy in patients with chronic obstructive pulmonary disease using machine learning models.
    Respir Med. 2025;248:108378.
    PubMed         Abstract available

  49. ALVAREZ-MARTINEZ CJ, Hernandez M, Velez J, Sanchez-Covisa J, et al
    Clinical and economic impact of concomitant heart failure in patients with exacerbated COPD.
    Respir Med. 2025;248:108381.
    PubMed         Abstract available

  50. KARAKURT G, Demireller M, Ucgun H, Guven O, et al
    EzPAP therapy versus non-invasive ventilation for hypercapnic chronic obstructive pulmonary disease exacerbation: a randomized clinical trial.
    Respir Med. 2025;248:108383.
    PubMed         Abstract available

  51. WANG H, Fan M, Wu J, Liu H, et al
    Development of a questionnaire on supportive care needs of patients with COPD combined with respiratory failure on noninvasive ventilators and evaluating its reliability and validity.
    Respir Med. 2025;248:108384.
    PubMed         Abstract available

  52. CHOI JY, Yoon HK, Kim Y, Jang JG, et al
    Comparison of chronic bronchitis definitions in COPD for predicting 10-year all-cause mortality.
    Respir Med. 2025;248:108389.
    PubMed         Abstract available

  53. BAKAKOS A, Sotiropoulou Z, Anagnostopoulos N, Vontetsianos A, et al
    Anti-inflammatory agents for the management of COPD - Quo Vadis?
    Respir Med. 2025;248:108396.
    PubMed         Abstract available

  54. MATERA MG, Page C, Cazzola M
    Sarcopenia as a treatable trait in COPD: From mechanisms to management.
    Respir Med. 2025;248:108401.
    PubMed         Abstract available

  55. ZHANG X, Xue J, Chang Y, Zhang R, et al
    Non-pharmacological interventions for fatigue in patients with chronic obstructive pulmonary disease: a systematic review and network meta-analysis.
    Respir Med. 2025;248:108409.
    PubMed         Abstract available

  56. HARRISON SL, Loughran KJ, Suri S, Franklin A, et al
    The continuous daily work of living with chronic obstructive pulmonary disease: An ethnographic study.
    Respir Med. 2025;248:108405.
    PubMed         Abstract available

  57. HANSEN FR, Pedersen DC, Madsen F, Backman H, et al
    Childhood body size and risk of chronic obstructive pulmonary disease in adulthood: a prospective cohort study.
    Respir Med. 2025;248:108416.
    PubMed         Abstract available


    Respir Res

  58. KELSEN SG, Maurer M, Waters M, Dash A, et al
    Safety and tolerability of astegolimab, an anti-ST2 monoclonal antibody: a narrative review.
    Respir Res. 2025;26:302.
    PubMed         Abstract available

  59. SANTUS P, Oresta B, Finocchiaro D, De Rosa P, et al
    Modeled reductions in COPD exacerbation rates, mortality, and related medical costs due to increased SITT adoption: PROMETHEUS Italy.
    Respir Res. 2025;26:296.
    PubMed         Abstract available

  60. GHOSH AJ, Chang KY, Moll M, Hess J, et al
    Genetic resilience to chronic obstructive pulmonary disease is a clinically distinct subtype in individuals with cigarette smoke exposure.
    Respir Res. 2025;26:297.
    PubMed         Abstract available


    Rev Mal Respir

  61. GUENDOUZ A, Matmour D, Benabdi S
    [The particularities of asthma in the elderly subject: A comparative study in an Algerian population].
    Rev Mal Respir. 2025 Oct 30:S0761-8425(25)00245.
    PubMed         Abstract available


    Thorax

  62. LUNDHOLM C, Caffrey Osvald E, Rhedin S, Almqvist C, et al
    Maternal BMI and smoking partly explain the association between maternal socio-economic position and offspring asthma.
    Thorax. 2025 Oct 28:thorax-2025-223330. doi: 10.1136/thorax-2025-223330.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.